August 19, 2009 - Uterine fibroid embolization (UFE), a minimally invasive interventional radiology treatment for women that cuts off blood flow to painful fibroids to kill the tumors, is highlighted as an appropriate treatment for women in a Clinical Therapeutics article in the Aug. 13 issue of the New England Journal of Medicine.

According to Scott C. Goodwin, M.D., FSIR, an interventional radiologist who co-authored the journal article "Uterine Fibroid Embolization," UFE is a safe, effective and minimally invasive option for women to consider.

Interventional radiologists use magnetic resonance imaging (or MRI) to determine if fibroids can be appropriately embolized, detect possible alternate causes for the symptoms, rule out misdiagnosis, identify which treatments are best suited for each patient and avoid ineffective treatments. UFE blocks tiny blood vessels that feed fibroids, causing the tumor(s) to die and symptoms to subside. An interventional radiologist uses imaging to guide a thin catheter to the uterine artery to treat the source of the disease internally, avoiding open surgery. The procedure offers less risk, less pain and a shorter recovery time compared to open surgery.

Goodwin noted that interventional radiologists can provide a second opinion and assess whether UFE is a treatment option.

Reference: "Uterine Fibroid Embolization," appears in the Aug. 13 issue of the New England Journal of Medicine, was co-written by Scott C. Goodwin, M.D., FSIR, professor and chair of radiological sciences at the University of California at Irvine, and James B. Spies, M.D., M.P.H., FSIR, professor of radiology and chair of the radiology department at Georgetown University Medical Center in Washington, D.C. Goodwin and Spies are SIR members; Goodwin is currently the SIR treasurer, and Spies is immediate past chair of SIR Foundation.

For more information: www.sirweb.org/


Related Content

News | Radiation Therapy

March 28, 2023 — People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart ...

Time March 28, 2023
arrow
News | Interventional Radiology

March 28, 2023 — Researchers found that a minimally invasive procedure combined with epidural steroid injection ...

Time March 28, 2023
arrow
News | Breast Imaging

March 23, 2023 — Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies ...

Time March 24, 2023
arrow
News | Breast Imaging

March 15, 2023 — In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer ...

Time March 15, 2023
arrow
News | Mammography

March 14, 2023 — Volpara Health Technologies, a global leader in software for the early detection of breast cancer ...

Time March 14, 2023
arrow
News | Artificial Intelligence

March 10, 2023 — Breast cancer undisputedly has the highest incidence rate in female patients. Moreover, out of the six ...

Time March 10, 2023
arrow
Feature | Breast Density

March 9, 2023 — Today, the U.S. Food and Drug Administration published updates to the mammography regulations to, among ...

Time March 09, 2023
arrow
Feature | Women's Health | By Paola Wisner, Andy Smith, PhD, and Nikos Gkanatsios, PhD

Mammography has long been a vital tool in the radiologist toolkit for breast cancer imaging. It is an essential ...

Time March 09, 2023
arrow
News | SIR

March 6, 2023 — The Society of Interventional Radiology Foundation today presented the Leaders in Innovation Award to ...

Time March 06, 2023
arrow
News | Artificial Intelligence

March 2, 2023 — Qure.ai, a London-based medical Artificial Intelligence (AI) imaging company, has announced a new ...

Time March 02, 2023
arrow
Subscribe Now